Cardiac Response to Strength Training in Hypertensive Individuals
Launched by UNIVERSIDAD CATÓLICA DEL MAULE · Apr 12, 2024
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how different levels of strength training—both high and low intensity—affect the heart's ability to control itself in people who have high blood pressure, known as hypertension. The goal is to see how these exercises can impact heart health in individuals diagnosed with this condition.
To be eligible for the study, participants must be adults who have been diagnosed with hypertension by a doctor. Unfortunately, those who have other serious health issues, injuries that affect their arms or legs, or other heart problems besides hypertension cannot join. If you participate, you can expect to engage in strength training exercises and help researchers understand how these workouts influence the heart’s function. The study is currently recruiting participants of all genders, so if you meet the criteria and are interested, this could be a great opportunity to contribute to important health research!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants exclusively diagnosed with hypertension by a medical professional
- Exclusion Criteria:
- • Participants with any other chronic medical condition
- • Subjects with any upper or lower limb injury that prevents strength training
- • Subjects with cardiovascular abnormalities other than hypertension
About Universidad Católica Del Maule
Universidad Católica del Maule is a distinguished academic institution in Chile, committed to advancing medical research and contributing to the field of healthcare through rigorous clinical trials. With a strong emphasis on ethical standards and scientific integrity, the university fosters innovative research initiatives aimed at improving patient outcomes and enhancing clinical practices. Collaborating with a network of healthcare professionals and researchers, Universidad Católica del Maule is dedicated to exploring new therapeutic avenues and ensuring the translation of research findings into real-world applications for the benefit of society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Talca, Maule, Chile
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported